Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/50559
DC FieldValueLanguage
dc.contributor.authorTorres, Fernandoen_US
dc.contributor.authorQuintana, Joséen_US
dc.contributor.authorEstévez, Franciscoen_US
dc.contributor.otherQuintana, Jose-
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherTorres Andon, Fernando-
dc.date.accessioned2018-11-24T16:59:34Z-
dc.date.available2018-11-24T16:59:34Z-
dc.date.issued2010en_US
dc.identifier.issn0899-1987en_US
dc.identifier.urihttp://hdl.handle.net/10553/50559-
dc.description.abstractFlavonoids are polyphenolic compounds which display a vast array of biological activities and are promising anticancer agents. In this study we investigated the effect of 5,7,3′-trihydroxy-3,4′-dimethoxyflavone (THDF) on viability of nine human tumor cell lines and found that it was highly cytotoxic against leukemia cells. THDF induced G2-M phase cell-cycle arrest and apoptosis through a caspase-dependent mechanism involving cytochrome c release, processing of multiple caspases (caspase-3, -6, -7, and -9) and cleavage of poly(ADP-ribose) polymerase. Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-xL conferred partial resistance to THDF-induced apoptosis. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases (MAPKs) family and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) and of extracellular signal-regulated kinases (ERK) 1/2. In the present study we report that THDF-induced cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. The results suggest that THDF could be useful in the development of novel anticancer agents.en_US
dc.languageengen_US
dc.relationDesarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicosen_US
dc.relationEvaluación de Tdf Como Potencial Fármaco Antitumoral.en_US
dc.relation.ispartofMolecular Carcinogenesisen_US
dc.sourceMolecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 (Mayo 2010)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320703 Carcinogénesisen_US
dc.subject.otherG(2)-M Phase Arresten_US
dc.subject.otherDifferential Regulationen_US
dc.subject.otherSignal-Transductionen_US
dc.subject.otherInduced Apoptosisen_US
dc.subject.otherMammalian-Cellsen_US
dc.subject.otherCancer Cellsen_US
dc.subject.otherJnken_US
dc.subject.otherQuercetinen_US
dc.subject.otherKinaseen_US
dc.subject.otherInhibitionen_US
dc.title5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathwayen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/mc.20619en_US
dc.identifier.scopus77953033838-
dc.identifier.isi000277311800004-
dcterms.isPartOfMolecular Carcinogenesis-
dcterms.sourceMolecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475-
dc.contributor.authorscopusid55366045300-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid7003810011-
dc.description.lastpage475en_US
dc.identifier.issue5-
dc.description.firstpage464en_US
dc.relation.volume49en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000277311800004-
dc.contributor.daisngid34941095-
dc.contributor.daisngid2952604-
dc.contributor.daisngid128315-
dc.contributor.daisngid384944-
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDD-5184-2009-
dc.description.numberofpages12en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Torres, F-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Estevez, F-
dc.date.coverdateMayo 2010en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr3,265-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorQuintana Aguiar, José Martín-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

27
checked on Nov 24, 2024

WEB OF SCIENCETM
Citations

26
checked on Nov 24, 2024

Page view(s)

53
checked on Dec 2, 2023

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.